CytoMed Therapeutics Limited Share Price
NASDAQ: GDTCCytoMed Therapeutics Limited Stock Performance
CytoMed Therapeutics Limited Share Price Today
As of 30 October 2026, CytoMed Therapeutics Limited's share price is $0.92. The stock opened at $0.92, compared to its previous close of $0.87. During today's trading session, CytoMed Therapeutics Limited's share price traded between $0.92 and $0.92, with an average price of $0.92. Over the past 52 weeks, the stock has recorded a high of $3.06 and a low of $0.74. In terms of performance, CytoMed Therapeutics Limited's share price has declined by 4.64% over the last six months and is down 58.93% on a year-on-year basis.
CytoMed Therapeutics Limited Share Price Chart
CytoMed Therapeutics Limited Annual Profit & Loss
All figures in USD
About CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
CytoMed Therapeutics Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.86 | $0.92 | +1.54% |
Sep 2026 | $0.81 | $0.91 | -4.71% |
Aug 2026 | $0.89 | $0.95 | +0.53% |
Jul 2026 | $0.99 | $0.95 | -10.38% |
Jun 2026 | $1.14 | $1.06 | -10.17% |
May 2026 | $0.99 | $1.18 | +21.78% |
Apr 2026 | $1.00 | $0.97 | -3.49% |
Mar 2026 | $1.04 | $1.00 | -3.46% |
Feb 2026 | $1.14 | $1.04 | +30.00% |
Jan 2026 | $1.31 | $0.80 | -41.18% |
Dec 2025 | $1.96 | $1.36 | -29.17% |
Nov 2025 | $1.94 | $1.92 | -14.67% |